DR. STEVEN ALAN FISCHKOFF, M.D.
Osteopathic Medicine at Canoe Brook Rd, Short Hills, NJ

License number
New Jersey MD034568E
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
5 Canoe Brook Rd, Short Hills, NJ 07078
Phone
(973) 376-0437

Professional information

Steven A Fischkoff Photo 1

Dr. Steven A Fischkoff, Short Hills NJ - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
5 Canoe Brook Rd, Short Hills 07078
(973) 376-0437 (Phone)
Certifications:
Internal Medicine, 1979, Medical Oncology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1976
Bellevue Hospital Center
Baltimore Cancer Rsch Ctr


Steven Fischkoff Photo 2

Treatment Of Sarcoidosis Using Placental Stem Cells

US Patent:
8562973, Oct 22, 2013
Filed:
Apr 6, 2011
Appl. No.:
13/081422
Inventors:
James W. Edinger - Belford NJ, US
Steven Alan Fischkoff - Short Hills NJ, US
Aleksandar Francki - Annandale NJ, US
Vladimir Jankovic - New York NY, US
Bitao Liang - Closter NJ, US
Philippe Martin - Hoboken NJ, US
Cynthia Ray - Branchburg NJ, US
Xiaokui Zhang - Livingston NJ, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
C12C 7/04
US Classification:
424 937, 424583
Abstract:
Methods of treating individuals having sarcoidosis or a sarcoidosis-related disease or disorder using placental cells are described. Also describe are kits comprising placental stem cells or a composition thereof that can be used in methods of treating sarcoidosis or a sarcoidosis-related disease or disorder.


Steven Fischkoff Photo 3

Tnf-Alpha Blocker Treatment For Enterocolitis Associated With Immunostimulatory Therapeutic Antibody Therapy

US Patent:
2007024, Oct 25, 2007
Filed:
Nov 8, 2006
Appl. No.:
11/557835
Inventors:
Steven Fischkoff - Short Hills NJ, US
Israel Lowy - Dobbs Ferry NY, US
Michael Yellin - Montclair NJ, US
James Yang - Silver Spring MD, US
International Classification:
A61K 39/395, A61K 38/17
US Classification:
424131100, 514012000
Abstract:
The present invention provides methods for treating adverse events related to immunotherapy. More specifically, the present invention provides methods for treating the enterocolitis associated with anti-CTLA-4 antibody immunotherapy.


Steven Fischkoff Photo 4

Prophylaxis And Treatment Of Enterocolitis Associated With Anti-Ctla-4 Antibody Therapy

US Patent:
2007024, Oct 18, 2007
Filed:
Nov 8, 2006
Appl. No.:
11/557844
Inventors:
Steven Fischkoff - Short Hills NJ, US
Israel Lowy - Dobbs Ferry NY, US
Stephan Targan - Santa Monica CA, US
James Yang - Silver Spring MD, US
International Classification:
A61K 39/395, A61K 31/56
US Classification:
424130100, 514044000
Abstract:
The present invention provides methods for reducing the incidence of adverse events related to immunotherapy. More specifically, the present invention provides methods for reducing the incidence of enterocolitis associated with anti-CTLA-antibody immunotherapy.


Steven Fischkoff Photo 5

Treatment Of Anemia Using Tnfalpha Inhibitors

US Patent:
2008019, Aug 14, 2008
Filed:
Apr 14, 2008
Appl. No.:
12/102682
Inventors:
Subhashis Banerjee - Hamden MA, US
Lori K. Taylor - Wadsworth IL, US
Clive E. Spiegler - Reading, GB
Daniel Edward Tracey - Harvard MA, US
Elliot K. Chartash - Randolph NJ, US
Rebacca S. Hoffman - Wilmette IL, US
William T. Barchuk - San Diego CA, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Westborough MA, US
Jochen G. Salfeld - North Grafton MA, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
ABBOTT BIOTECHNOLOGY LTD. - Hamilton
International Classification:
A61K 39/395, A61P 7/06
US Classification:
4241721
Abstract:
Methods for treating anemia in which TNFα activity is detrimental are described.


Steven Fischkoff Photo 6

Treatment Of Pain Using Tnfalpha Inhibitors

US Patent:
2004013, Jul 15, 2004
Filed:
Jul 18, 2003
Appl. No.:
10/623035
Inventors:
Subhashis Banerjee - Shrewsbury MA, US
Lori Taylor - Wadsworth IL, US
Clive Spiegler - Reading, GB
Daniel Tracey - Harvard MA, US
Elliot Chartash - Randolph NJ, US
Rebecca Hoffman - Wilmette IL, US
William Barchuk - Madison NJ, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Westborough MA, US
Jochen Salfeld - North Grafton NC, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
Abbott Biotechnology Ltd. - Hamilton
International Classification:
A61K039/395
US Classification:
424/145100
Abstract:
Methods for treating pain syndromes in which TNF activity is detrimental are described.


Steven Fischkoff Photo 7

Treatment Of Vasculitides Using Tnfalpha Inhibitors

US Patent:
2004013, Jul 15, 2004
Filed:
Jul 18, 2003
Appl. No.:
10/622210
Inventors:
Subhashis Banerjee - Shrewsbury MA, US
Lori Taylor - Wadsworth IL, US
Clive Spiegler - , US
Daniel Tracey - Harvard MA, US
Elliot Chartash - Randolph NJ, US
Rebecca Hoffman - Wilmette IL, US
William Barchuk - Madison NJ, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Shrewsbury MA, US
Jochen Salfeld - North Grafton MA, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
Abbott Laboratories S.A. - Baar
International Classification:
A61K039/395
US Classification:
424/145100
Abstract:
Methods for treating vasculitides in which TNF activity is detrimental are described.


Steven Fischkoff Photo 8

Treatment Of Pulmonary Disorders Using Tnfalpha Inhibitor

US Patent:
2004013, Jul 8, 2004
Filed:
Jul 18, 2003
Appl. No.:
10/623076
Inventors:
Subhashis Banerjee - Shrewsbury MA, US
Lori Taylor - Wadsworth IL, US
Clive Spiegler - Reading, GB
Daniel Tracey - Harvard MA, US
Elliot Chartash - Randolph NJ, US
Rebecca Hoffman - Wilmette IL, US
William Barchuk - Madison NJ, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Westborough MA, US
Jochen Salfeld - North Grafton MA, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
Abbott Biotechnology Ltd. - Hamilton
International Classification:
A61K039/395
US Classification:
424/145100
Abstract:
Methods of treating pulmonary disorders comprising administering TNF inhibitors, including TNF antibodies are described.


Steven Fischkoff Photo 9

Treatment Of Coronary Disorders Using Tnfalpha Inhibitors

US Patent:
2004012, Jul 1, 2004
Filed:
Jul 18, 2003
Appl. No.:
10/623065
Inventors:
Subhashis Banerjee - Shrewsbury MA, US
Lori Taylor - Wadsworth IL, US
Clive Spiegler - Reading, GB
Daniel Tracey - Harvard MA, US
Elliot Chartash - Randolph NJ, US
Rebecca Hoffman - Wilmette IL, US
William Barchuk - Madison NJ, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Westborough MA, US
Jochen Salfeld - North Grafton MA, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
Abbott Biotechnology Ltd. - Hamilton
International Classification:
A61K039/395, C12Q001/68
US Classification:
424/145100
Abstract:
Methods for treating coronary disease in which TNF activity is detrimental are described.


Steven Fischkoff Photo 10

Treatment Of Spondyloarthropathies Using Tnfalpha Inhibitors

US Patent:
2007020, Aug 30, 2007
Filed:
Jul 18, 2003
Appl. No.:
10/623039
Inventors:
Subhashis Banerjee - Shrewsbury MA, US
Lori Taylor - Wadsworth IL, US
Clive Spiegler - , US
Daniel Tracey - Harvard MA, US
Elliot Chartash - Randolph NJ, US
Rebecca Hoffman - Wilmette IL, US
William Barchuk - Madison NJ, US
Philip Yan - Vernon Hills IL, US
Anwar Murtaza - Shrewsbury MA, US
Jochen Salfeld - North Grafton MA, US
Steven Fischkoff - Short Hills NJ, US
Assignee:
Abbott Laboratories S.A. - Baar
International Classification:
A61K 39/395, A61K 31/405, A61K 31/192, C07K 16/24
US Classification:
424145100, 530388230, 514420000, 514569000, 514570000
Abstract:
Methods for treating spondyloarthropathies, including ankylosing spondylitis, using TNFα inhibitors are described.